Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Primary Immunodeficiency Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00176865
What this trial is testing

Stem Cell Transplant for Immunologic or Histiocytic Disorders

Who this might be right for
Hemophagocytic LymphohistiocytosisX-Linked Lymphoproliferative DisordersChediak-Higashi Syndrome+3 more
Masonic Cancer Center, University of Minnesota 19
Not applicableUnknownNCT04172181
What this trial is testing

Multi-center Clinical Study of Cord Blood Stem Cell Transplantation for SCID

Who this might be right for
Severe Combined Immunodeficiency Disease
Children's Hospital of Fudan University 50
Not applicableUnknownNCT06324877
What this trial is testing

Ataxia-telangiectasia: Treating Mitochondrial Dysfunction With Nicotinamide Riboside

Who this might be right for
Ataxia Telangiectasia
The University of Queensland 10
Post-approval studies (Phase 4)Study completedNCT03033745
What this trial is testing

Safety and Tolerability of Higher Infusion Parameters of IgPro20 (Hizentra) in Subjects With Primary Immunodeficiency (PID)

Who this might be right for
Primary Immunodeficiency
CSL Behring 49
Testing effectiveness (Phase 2)Ended earlyNCT01182675
What this trial is testing

Hematopoietic Stem Cell Transplantation (HSCT) for Children With SCID Utilizing Alemtuzumab, Plerixafor & Filgrastim

Who this might be right for
Severe Combined Immunodeficiency
University of California, San Francisco 7
Testing effectiveness (Phase 2)Active Not RecruitingNCT05120830
What this trial is testing

NTLA-2002 in Adults With Hereditary Angioedema (HAE)

Who this might be right for
Hereditary Angioedema
Intellia Therapeutics 37
Large-scale testing (Phase 3)Study completedNCT04561115
What this trial is testing

Evaluate the Pharmacokinetics, Safety, and Tolerability of Immune Globulin (Human) 10% (Gamunex-C) PEG Process (IVIG-PEG) Compared to Gamunex-C in Participants With Primary Humoral Immunodeficiency

Who this might be right for
Primary Immunodeficiency
Grifols Therapeutics LLC 33
Early research (Phase 1)Active Not RecruitingNCT02337985
What this trial is testing

Gene Therapy and Combination Chemotherapy in Treating Patients With AIDS-Related Non-Hodgkin Lymphoma

Who this might be right for
AIDS-Related Burkitt LymphomaAIDS-Related Diffuse Large B-cell LymphomaAIDS-Related Plasmablastic Lymphoma+3 more
City of Hope Medical Center 10
Large-scale testing (Phase 3)Ended earlyNCT01275976
What this trial is testing

Effect of C1-esterase Inhibitor on Systemic Inflammation in Trauma Patients With a Femur or Pelvic Fracture

Who this might be right for
TraumaInflammationSepsis+1 more
UMC Utrecht 11
Not applicableStudy completedNCT06564792
What this trial is testing

Contingency Management in HIV Care for Both Stimulant Use & ART Adherence

Who this might be right for
Stimulant Use (Diagnosis)Hiv
University of California, San Francisco 37
Testing effectiveness (Phase 2)Study completedNCT00782106
What this trial is testing

Study to Determine the Dose of Recombinant Human Hyaluronidase Needed to Infuse a Full Dose of IGIV Subcutaneously

Who this might be right for
Primary Immunodeficiency Diseases (PID)
Baxalta now part of Shire 11
Post-approval studies (Phase 4)UnknownNCT05070455
What this trial is testing

An Open Label, Multicenter Study to Evaluate the Pharmacokinetics, Efficacy and Safety of ASCENIV™ (IGIV) in Pediatric Subjects With Primary Immunodeficiency Diseases (PIDD)

Who this might be right for
Primary Immune Deficiency
ADMA Biologics, Inc. 12
Testing effectiveness (Phase 2)Looking for participantsNCT03538899
What this trial is testing

Autologous Gene Therapy for Artemis-Deficient SCID

Who this might be right for
Severe Combined Immunodeficiency
University of California, San Francisco 24
Testing effectiveness (Phase 2)Looking for participantsNCT04319367
What this trial is testing

A Randomised Placebo Controlled Trial of ART Plus Dual Long-acting HIV-specific Broadly Neutralising Antibodies (bNAbs).

Who this might be right for
HIV/AIDS and Infections
Imperial College London 72
Large-scale testing (Phase 3)Study completedNCT00538915
What this trial is testing

Open Label, Phase III Study of NABI-IGIV 10% [Immune Globulin Intravenous(Human), 10%] In Subjects With Primary Immune Deficiency Disorders (PIDD)

Who this might be right for
Primary Immune Deficiency Disorders (PIDD)
ADMA Biologics, Inc. 63
Not applicableStudy completedNCT01059526
What this trial is testing

Observational Safety Study for KALBITOR (Ecallantide) in the Treatment of Acute Attacks of Hereditary Angioedema

Who this might be right for
Hereditary Angioedema (HAE)
Shire 81
Not applicableStudy completedNCT05784415
What this trial is testing

Observational Study of People Living With HIV Treated With CD19-directed CAR T Cell

Who this might be right for
LeukemiaLeukemia, LymphoblasticLymphoma, Large B-Cell, Diffuse+7 more
AIDS Malignancy Consortium 30
Very early researchEnded earlyNCT01694381
What this trial is testing

Research Into the Effect of a Clot-dissolving Agent and Its Inhibitor

Who this might be right for
Acute Ischemic Stroke
TSI, LLC 8
Large-scale testing (Phase 3)Study completedNCT00102960
What this trial is testing

Anti-HIV Drugs for Treating Infants Who Acquired HIV Infection at Birth

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 377
Early research (Phase 1)UnknownNCT05531890
What this trial is testing

Comparative Bioavailability of Betamethasone Oral Solution Metered Spray (GTX-102) in Healthy Subjects

Who this might be right for
Ataxia Telangiectasia
Grace Therapeutics Inc. 48
Next Page